JP2009519280A5 - - Google Patents

Download PDF

Info

Publication number
JP2009519280A5
JP2009519280A5 JP2008544872A JP2008544872A JP2009519280A5 JP 2009519280 A5 JP2009519280 A5 JP 2009519280A5 JP 2008544872 A JP2008544872 A JP 2008544872A JP 2008544872 A JP2008544872 A JP 2008544872A JP 2009519280 A5 JP2009519280 A5 JP 2009519280A5
Authority
JP
Japan
Prior art keywords
methylthiazol
ethyl
ureido
alkyl
imidazol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008544872A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009519280A (ja
Filing date
Publication date
Priority claimed from GBGB0525671.4A external-priority patent/GB0525671D0/en
Application filed filed Critical
Publication of JP2009519280A publication Critical patent/JP2009519280A/ja
Publication of JP2009519280A5 publication Critical patent/JP2009519280A5/ja
Pending legal-status Critical Current

Links

JP2008544872A 2005-12-16 2006-12-13 有機化合物 Pending JP2009519280A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0525671.4A GB0525671D0 (en) 2005-12-16 2005-12-16 Organic compounds
PCT/EP2006/012018 WO2007068473A2 (en) 2005-12-16 2006-12-13 Organic compounds

Publications (2)

Publication Number Publication Date
JP2009519280A JP2009519280A (ja) 2009-05-14
JP2009519280A5 true JP2009519280A5 (enExample) 2012-02-02

Family

ID=35736289

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008544872A Pending JP2009519280A (ja) 2005-12-16 2006-12-13 有機化合物

Country Status (11)

Country Link
US (1) US7754746B2 (enExample)
EP (2) EP2357179A1 (enExample)
JP (1) JP2009519280A (enExample)
KR (1) KR20080068744A (enExample)
CN (1) CN101374823A (enExample)
AU (1) AU2006326255A1 (enExample)
BR (1) BRPI0619835A2 (enExample)
CA (1) CA2631051A1 (enExample)
GB (1) GB0525671D0 (enExample)
RU (1) RU2008128566A (enExample)
WO (1) WO2007068473A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR038703A1 (es) * 2002-02-28 2005-01-26 Novartis Ag Derivados de 5-feniltiazol y uso como inhibidor de quinasa p i 3
TW200519106A (en) 2003-05-02 2005-06-16 Novartis Ag Organic compounds
GB0610243D0 (en) 2006-05-23 2006-07-05 Novartis Ag Organic compounds
AU2008340053A1 (en) 2007-12-20 2009-07-02 Novartis Ag Thiazole derivatives used as PI 3 kinase inhibitors
AU2009286604B2 (en) 2008-08-29 2015-05-28 Onxeo Dk, Branch Of Onxeo S.A., France Novel urea and thiourea derivatives
UA104147C2 (uk) 2008-09-10 2014-01-10 Новартис Аг Похідна піролідиндикарбонової кислоти та її застосування у лікуванні проліферативних захворювань
US8293753B2 (en) 2009-07-02 2012-10-23 Novartis Ag Substituted 2-carboxamide cycloamino ureas
KR20120046723A (ko) 2009-07-02 2012-05-10 노파르티스 아게 Ｐｉ３ｋ 억제제로서 유용한 2-카르복스아미드 시클로아미노 우레아

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5451700A (en) 1991-06-11 1995-09-19 Ciba-Geigy Corporation Amidino compounds, their manufacture and methods of treatment
US6166037A (en) 1997-08-28 2000-12-26 Merck & Co., Inc. Pyrrolidine and piperidine modulators of chemokine receptor activity
GB9913083D0 (en) 1999-06-04 1999-08-04 Novartis Ag Organic compounds
KR100439357B1 (ko) 1999-05-04 2004-07-07 쉐링 코포레이션 Ｃｃｒ５ 길항제로서 유용한 피페리딘 유도체
IL145741A0 (en) 1999-05-04 2002-07-25 Schering Corp Piperazine derivatives useful as ccrs antagonists
AR038703A1 (es) * 2002-02-28 2005-01-26 Novartis Ag Derivados de 5-feniltiazol y uso como inhibidor de quinasa p i 3
GB0320197D0 (en) * 2003-08-28 2003-10-01 Novartis Ag Organic compounds

Similar Documents

Publication Publication Date Title
RU2458920C2 (ru) Новые соединения
RU2454415C9 (ru) Производное индола
US20080261952A1 (en) Aryl Urea Derivatives for Treating Obesity
RU2011146363A (ru) Производные n-ацил-n-фенилпиперазина, используемые (кроме того) для профилактики или лечения диабета
JP2008517945A5 (enExample)
JP2010215644A5 (enExample)
JP2013517283A5 (enExample)
HRP20130174T1 (hr) Derivati pirimidina za lijeäśenje astme, kopb, alergijskog rinitisa, alergijskog konjuktivitisa, atopijskog dermatitisa, karcinoma, hepatitisa b, hepatitisa c, hiv, hpv, bakterijskih infekcija i dermatoze
US20100234377A1 (en) Piperazine compounds for the inhibition of haematopoietic prostaglandin d synthase
HRP20160678T1 (hr) Derivati 2-(1,2,3-triazol-2-il)benzamida i 3-(1,2,3-triazol-2-il)pikolinamida kao antagonisti receptora oreksina
AR048306A1 (es) Derivados de acidos carboxilicos aromaticos con capacidad moduladora de los niveles de insulina, composiciones farmaceuticas que los contienen y su uso en el tratamiento de trastornos metabolicos que responden a la regulacion de gpr40
JP2013507449A5 (enExample)
NZ573832A (en) N-(4-{ 2-[4-aryl-piperazin-1-yl]ethyl} cyclohexyl)-acetamide derivatives for the treatment of neuropsychiatric disorders
JP2007509130A5 (enExample)
ZA200403137B (en) Dibenzylamine compound and medicinal use thereof
BRPI0715513A2 (pt) inibidores de epàxido hidrolase solével
RU2009101911A (ru) Производные пиридина и пиразина в качестве ингибиторов mnk-киназы
CA2488202A1 (en) 1-aryl-4-substituted piperazine derivatives for use as ccr1 antagonists for the treatment of inflammation and immune disorders
ME02648B (me) Jedinjenje pirazin karboksamida
RU2008112221A (ru) Соединения ряда изоиндолимидов, их композиции и способы применения
JP2013530240A5 (enExample)
CA2643924A1 (en) Isoxazole derivatives as calcium channel blockers
RU2012129737A (ru) Замещенные бензамидные производные
JP2010540462A5 (enExample)
JP2013517273A5 (enExample)